Hemlibra_Emicizumab_ Summary of product characteristics v1
Hemlibra_Emicizumab_ Summary of product characteristics v1
Hemlibra_Emicizumab_ Summary of product characteristics v1
Hemlibra_Emicizumab_ Public assessment summary reportv1
Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg Dispersible_public assessment summary report
Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg Dispersible_Summary of product characteristics
INIGAST 40 Summary of product characteristics v1
ALLTERA 50 Summary of product characteristics v1
Food and Medicine Administration Proclamation 1112